Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
MannKind Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MNKD
Nasdaq
2834
https://mannkindcorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for MannKind Corp
MannKind Announces CFO Transition
- Mar 26th, 2024 8:05 pm
Jim Cramer Says You Should Avoid These 11 Stocks
- Mar 25th, 2024 3:45 pm
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
- Mar 11th, 2024 10:05 am
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
- Mar 5th, 2024 11:05 am
MannKind Corporation Announces Participation at Upcoming Conferences
- Mar 4th, 2024 6:01 pm
Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts
- Mar 3rd, 2024 12:14 pm
MannKind Full Year 2023 Earnings: Beats Expectations
- Feb 29th, 2024 10:34 am
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 2:30 pm
Q4 2023 MannKind Corp Earnings Call
- Feb 28th, 2024 1:11 pm
MannKind (MNKD) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 6:00 am
Here's What Key Metrics Tell Us About MannKind (MNKD) Q4 Earnings
- Feb 27th, 2024 11:00 pm
MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates
- Feb 27th, 2024 10:35 pm
MannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023
- Feb 27th, 2024 9:46 pm
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
- Feb 27th, 2024 9:00 pm
MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
- Feb 20th, 2024 11:00 am
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
- Feb 15th, 2024 11:05 am
13 Best NASDAQ Penny Stocks To Invest In
- Feb 12th, 2024 5:30 pm
Analysts Are Optimistic We'll See A Profit From MannKind Corporation (NASDAQ:MNKD)
- Jan 29th, 2024 10:38 am
3 Biotech Stocks to Sell in January Before They Crash and Burn
- Jan 25th, 2024 10:29 pm
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
- Jan 2nd, 2024 11:05 am
Scroll